The peroxisome proliferator-activated receptor ß/Î´ agonist GW0742 has direct protective effects on right heart hypertrophy.

Kojonazarov, Baktybek; Luitel, Himal; Sydykov, Akylbek; Dahal, Bhola K; Paul-Clark, Mark J; Bonvini, Sara; Reed, Anna; Schermuly, Ralph T; Mitchell, Jane A

Kojonazarov, Baktybek; Luitel, Himal; Sydykov, Akylbek; Dahal, Bhola K; Paul-Clark, Mark J; Bonvini, Sara; Reed, Anna; Schermuly, Ralph T; Mitchell, Jane A.

Afiliación

Kojonazarov B; Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Luitel H; Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Sydykov A; Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Dahal BK; Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Paul-Clark MJ; Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Bonvini S; Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Reed A; Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Schermuly RT; Universities of Giessen and Marburg Lung Center, Giessen, Germany.
Mitchell JA; Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom.

Pulm Circ ; 3(4): 926-35, 2013 Dec.

Article en En | MEDLINE | ID: mdl-25006409

Palabras clave

angiopoietin-like 4; heart failure; peroxisome proliferatoractivated receptor (PPAR) ß; pulmonary hypertension; right ventricular function

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pulm Circ Año: 2013 Tipo del documento: Article País de afiliación: Alemania